Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes.

Holman RR, Bethel MA, Mentz RJ, Thompson VP, Lokhnygina Y, Buse JB, Chan JC, Choi J, Gustavson SM, Iqbal N, Maggioni AP, Marso SP, Öhman P, Pagidipati NJ, Poulter N, Ramachandran A, Zinman B, Hernandez AF; EXSCEL Study Group.

N Engl J Med. 2017 Sep 28;377(13):1228-1239. doi: 10.1056/NEJMoa1612917. Epub 2017 Sep 14.

PMID:
28910237
2.

Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.

PMID:
28854085
3.

Impact of 25-hydroxyvitamin D, free and bioavailable fractions of vitamin D, and vitamin D binding protein levels on metabolic syndrome components.

Pelczyńska M, Grzelak T, Sperling M, Bogdański P, Pupek-Musialik D, Czyżewska K.

Arch Med Sci. 2017 Jun;13(4):745-752. doi: 10.5114/aoms.2016.58594. Epub 2016 Mar 16.

4.

The effect of orlistat versus metformin on body composition and insulin resistance in obese premenopausal women: 3-month randomized prospective open-label study.

Kujawska-Łuczak M, Musialik K, Szulińska M, Swora-Cwynar E, Kargulewicz A, Grzymisławska M, Pupek-Musialik D, Bogdański P.

Arch Med Sci. 2017 Jun;13(4):725-731. doi: 10.5114/aoms.2016.62014. Epub 2016 Aug 29.

5.

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.

Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group.

N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12.

6.

3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.

le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group.

Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23.

PMID:
28237263
7.

Forum for internal medicine: opinions and controversies.

Pupek-Musialik D.

Pol Arch Med Wewn. 2016 Nov 30;126(11):942. doi: 10.20452/pamw.3687. Epub 2016 Nov 30. No abstract available.

8.

Concentrations of omentin and vaspin versus insulin resistance in obese individuals.

Sperling M, Grzelak T, Pelczyńska M, Jasinska P, Bogdanski P, Pupek-Musialik D, Czyzewska K.

Biomed Pharmacother. 2016 Oct;83:542-547. doi: 10.1016/j.biopha.2016.07.012. Epub 2016 Jul 21.

PMID:
27449535
9.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.

10.

Effects of endurance and endurance-strength exercise on biochemical parameters of liver function in women with abdominal obesity.

Skrypnik D, Ratajczak M, Karolkiewicz J, Mądry E, Pupek-Musialik D, Hansdorfer-Korzon R, Walkowiak J, Jakubowski H, Bogdański P.

Biomed Pharmacother. 2016 May;80:1-7. doi: 10.1016/j.biopha.2016.02.017. Epub 2016 Mar 12.

PMID:
27133033
11.

The effect of L-arginine and ascorbic acid on the visceral fat and the concentrations of metalloproteinases 2 and 9 in high-fat-diet rats.

Kujawska-Łuczak M, Suliburska J, Markuszewski L, Pupek-Musialik D, Jabłecka A, Bogdański P.

Endokrynol Pol. 2015;66(6):526-32. doi: 10.5603/EP.2015.0065.

12.

Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.

Mancia G, Omboni S, Chazova I, Coca A, Girerd X, Haller H, Parati G, Pauletto P, Pupek-Musialik D, Svyshchenko Y; FELT Study Group.

J Hypertens. 2016 Jan;34(1):139-48. doi: 10.1097/HJH.0000000000000767.

PMID:
26630216
13.

Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes.

Fulcher G, Matthews DR, Perkovic V, de Zeeuw D, Mahaffey KW, Mathieu C, Woo V, Wysham C, Capuano G, Desai M, Shaw W, Vercruysse F, Meininger G, Neal B; CANVAS trial collaborative group.

Diabetes Obes Metab. 2016 Jan;18(1):82-91. doi: 10.1111/dom.12589. Epub 2015 Dec 8.

PMID:
26450639
14.

Effect of L-arginine supplementation on insulin resistance and serum adiponectin concentration in rats with fat diet.

Miczke A, Suliburska J, Pupek-Musialik D, Ostrowska L, Jabłecka A, Krejpcio Z, Skrypnik D, Bogdański P.

Int J Clin Exp Med. 2015 Jul 15;8(7):10358-66. eCollection 2015.

15.

2015 guidelines for the management of hypertension. Recommendations of the Polish Society of Hypertension - short version.

Tykarski A, Narkiewicz K, Gaciong Z, Januszewicz A, Litwin M, Kostka-Jeziorny K, Adamczak M, Szczepaniak-Chicheł L, Chrostowska M, Czarnecka D, Dzida G, Filipiak KJ, Gąsowski J, Głuszek J, Grajek S, Grodzicki T, Kawecka-Jaszcz K, Wożakowska-Kapłon B, Begier-Krasińska B, Manitius J, Myśliwiec M, Niemirska A, Prejbisz A, Pupek-Musialik D, Brzezińska-Rajszys G, Stolarz-Skrzypek K, Szadkowska A, Tomasik T, Widecka K, Więcek A, Windak A, Wolf J, Zdrojewski T, Żurowska A.

Kardiol Pol. 2015;73(8):676-700. doi: 10.5603/KP.2015.0157. No abstract available.

PMID:
26304155
16.

Relationship between deficiency of vitamin D and exponents of metabolic syndrome.

Kramkowska M, Grzelak T, Walczak M, Bogdanski P, Pupek-Musialik D, Czyzewska K.

Eur Rev Med Pharmacol Sci. 2015 Jun;19(12):2180-7.

17.

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.

Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group.

N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892.

18.

Plasma ghrelin and interleukin-6 levels correlate with body mass index and arterial blood pressure in males with essential hypertension.

Gibas-Dorna M, Nowak D, Piatek J, Pupek-Musialik D, Krauss H, Kopczynski P.

J Physiol Pharmacol. 2015 Jun;66(3):367-72.

19.

Effects of Endurance and Endurance Strength Training on Body Composition and Physical Capacity in Women with Abdominal Obesity.

Skrypnik D, Bogdański P, Mądry E, Karolkiewicz J, Ratajczak M, Kryściak J, Pupek-Musialik D, Walkowiak J.

Obes Facts. 2015;8(3):175-87. doi: 10.1159/000431002. Epub 2015 May 8.

20.

[The analysis of the influence of short term physical effort on selected endothelial function parameters and blood vessels stiffness features among young and healthy men].

Jerzykowska S, Cymerys M, Roszak M, Wysocka E, Michalak S, Pupek-Musialik D.

Pol Merkur Lekarski. 2014 Jun;36(216):373-8. Polish.

PMID:
25095634

Supplemental Content

Loading ...
Support Center